Src family kinases regulate renal epithelial dedifferentiation through activation of EGFR/PI3K signaling

Shougang Zhuang1, Meili Duan, Yan Yan

  • 1Department of Nephrology, Shanghai East Hospital, Tongji University School of Medicine, Shanghai, China. szhuang@lifespan.org

Insights

Kidney cells dedifferentiate during repair, a process driven by Src family kinases (SFKs) activating the epidermal growth factor receptor (EGFR)/phosphoinositide-3-kinase (PI3K) pathway. This pathway is crucial for renal tubular cell dedifferentiation and outgrowth.

Area of Science:

  • Cell Biology
  • Renal Physiology
  • Molecular Signaling

Background:

  • Dedifferentiation of renal tubular cells is a critical initial step in kidney repair following injury.
  • The molecular mechanisms governing renal proximal tubular cell (RPTC) dedifferentiation remain largely uncharacterized.
  • Understanding these mechanisms is vital for developing therapeutic strategies for acute kidney injury.

Purpose of the Study:

  • To investigate the signaling pathways involved in the dedifferentiation of primary cultured RPTCs.
  • To elucidate the role of specific kinases, including Src, EGFR, AKT, and ERK1/2, in RPTC dedifferentiation.
  • To determine the upstream regulators and downstream effectors of RPTC dedifferentiation.

Main Methods:

  • Primary culture of rat proximal renal tubular cells (RPTCs).
  • Assessment of RPTC dedifferentiation by monitoring vimentin and cytokeratin-18 expression.
  • Pharmacological inhibition of signaling pathways including Src family kinases (SFKs), epidermal growth factor receptor (EGFR), PI3K/AKT, and ERK1/2.
  • Analysis of protein phosphorylation levels (Src, EGFR, AKT, ERK1/2) using Western blotting.
  • Evaluation of RPTC proliferation and migration following pathway inhibition.

Main Results:

  • RPTC dedifferentiation, marked by increased vimentin and decreased cytokeratin-18, occurred within 72 hours of culture.
  • Phosphorylation of Src, EGFR, AKT, and ERK1/2 increased during early culture stages.
  • Inhibition of SFKs or EGFR blocked phosphorylation of downstream kinases (AKT, ERK1/2) and prevented RPTC dedifferentiation.
  • Inactivation of the PI3K/AKT pathway inhibited dedifferentiation, while ERK1/2 pathway inhibition did not.
  • SFK, EGFR, and PI3K/AKT inhibition abrogated RPTC outgrowth, with SFK inhibition also reducing proliferation and migration.

Conclusions:

  • Src family kinases (SFKs) play a pivotal role in mediating RPTC dedifferentiation.
  • SFK activation leads to RPTC dedifferentiation via the epidermal growth factor receptor (EGFR)/phosphoinositide-3-kinase (PI3K) signaling pathway.
  • Targeting SFKs, EGFR, or PI3K/AKT may offer therapeutic potential for enhancing renal repair.

Related Concept Videos

PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
Receptor Tyrosine Kinases01:26

Receptor Tyrosine Kinases

Receptor tyrosine kinases or RTKs are membrane-bound receptors that phosphorylate specific tyrosine on protein substrates. RTKs regulate cellular growth, differentiation, survival, and migration. They contain an extracellular ligand binding domain, a transmembrane domain, and a cytosolic tail with intrinsic kinase activity. Several extracellular signaling molecules activate RTKs in one or more ways and relay the signal downstream. Ligands such as platelet-derived growth factor (PDGF) or...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR activation may...